Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?

Eur Respir J. 2020 Jul 23;56(1):2001369. doi: 10.1183/13993003.01369-2020. Print 2020 Jul.

Abstract

Rapid adoption of new diagnostic tools, parallel process of research and implementation, decentralisation of services, the use of personal protective equipment, as well as strong partnership and collaboration, could strengthen the fight against COVID-19 https://bit.ly/2XupDNe

Publication types

  • Letter

MeSH terms

  • COVID-19
  • Coronavirus Infections* / diagnosis
  • Coronavirus Infections* / therapy
  • Humans
  • Interdisciplinary Communication*
  • Pandemics*
  • Pneumonia, Viral* / diagnosis
  • Pneumonia, Viral* / therapy
  • South Africa
  • Tuberculosis, Multidrug-Resistant* / diagnosis
  • Tuberculosis, Multidrug-Resistant* / therapy